ASS1 and systemic lupus erythematosus: However, in systemic lupus erythematosus (SLE) patients, abnormal activation of the argininosuccinate synthase pathway in immune cells can trigger autoimmune responses and exacerbate damage to organs such as the skin and kidneys (60).